Estimating the societal cost of heroin dependence in an Australian population engaged in treatment or harm reduction services

被引:0
|
作者
Hall, Natasha [1 ]
Le, Long [2 ]
Abimanyi-Ochom, Julie [1 ]
Marel, Christina [3 ]
Mills, Katherine [3 ]
Teesson, Maree [3 ]
Mihalopoulos, Cathrine [2 ]
机构
[1] Deakin Univ, Sch Hlth & Social Dev, 221 Burwood Highway, Burwood, Vic 3125, Australia
[2] Monash Univ, Publ Hlth & Preventat Med, Melbourne, Australia
[3] Univ Sydney, Ctr Res Excellence Mental Hlth & Subst Use, Sydney, Australia
关键词
Heroin dependence; Longitudinal cost of illness; Societal costs; PSYCHIATRIC COMORBIDITY; GLOBAL EPIDEMIOLOGY; MENTAL-DISORDERS; NATIONAL-SURVEY; SUBSTANCE USE; INJECT DRUGS; USERS; ADULTS; HEALTH; EMPLOYMENT;
D O I
10.1016/j.drugalcdep.2024.112447
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Heroin dependence is a public health concern in Australia. High mortality rates, increased risk of physical/mental health comorbidities and increased risk of social issues contribute to a high personal and societal cost. The aim of this paper is to understand the societal cost of heroin dependence in an Australian population. Methods: A longitudinal cohort study of 600 people with heroin dependence were interviewed at five timepoints. Resource use was determined from interviews and was multiplied by unit costs to estimate the annual healthcare, productivity, crime and other costs (homelessness, heroin drug and prison costs). The monetary value of premature mortality was calculated using the value of a statistical life year method. Results: The annual mean societal cost of heroin dependence in Australia was A$120,599/person. This included healthcare costs (A$10,055), lost productivity costs (A$63,158), crime costs (A$7204) and other costs (A $40,182). Healthcare costs, lost productivity costs, crime costs and other costs trended downwards over the five waves. Lost productivity was the highest cost contributor (52 %), followed by heroin drug (25 %). The estimated number of life years lost due to heroin over the 11-year study period was 2703 years, which approximates to a monetary value of premature death of $213 million. Discussion and conclusions: The significant societal cost emphasises the importance of providing resources to heroin dependence. The cost of lost productivity, crime and heroin contributed to over 80 % of the total costs, which highlights the illicit nature and reduced capacity to work contributes to the high costs to society.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Estimating the societal cost of heroin dependence in Australia
    Hall, Natasha Yvonne
    Le, Long
    Abimanyi-Ochom, Julie
    Marel, Christina
    Mills, Katherine L.
    Teesson, Maree
    Mihalopoulos, Cathy
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S84 - S84
  • [2] Harm-Reduction as Risk Decreasing Strategy in Heroin Dependence
    Vasile, Daniel
    PROCEEDINGS OF THE WORLD MEDICAL CONFERENCE, 2010, : 16 - 16
  • [3] Harm-Reduction as Risk Decreasing Strategy in Heroin Dependence
    Vasile, Daniel
    PROCEEDINGS OF THE WORLD MEDICAL CONFERENCE, 2010, : 294 - +
  • [4] Supply control and harm reduction: lessons from the Australian heroin 'drought'
    Weatherburn, D
    Jones, C
    Freeman, K
    Makkai, T
    ADDICTION, 2003, 98 (01) : 83 - 91
  • [5] Treatment of heroin misuse and deviant sexual thoughts: harm reduction or collusion?
    Milton, J
    McLean, P
    JOURNAL OF FORENSIC PSYCHIATRY, 1999, 10 (03): : 679 - 686
  • [6] Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence
    Le Houezec, Jacques
    Aubin, Henri-Jean
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1959 - 1967
  • [7] The impact of harm-reduction-based methadone treatment on mortality among heroin users
    Langendam, MW
    van Brussel, GHA
    Coutinho, RA
    van Ameijden, EJC
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2001, 91 (05) : 774 - 780
  • [8] Estimating the cost of ROP treatment and services: A mathematical Model
    Mangalesh, Shwetha
    Vinekar, Anand
    Kulkarni, Suhruta
    Shainesh, G.
    Jayadev, Chaitra
    Bauer, Noel
    Shetty, Bhujang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Estimating the number of people who inject drugs and the coverage of harm reduction services in Canada
    Jacka, B.
    Larney, S.
    Hoj, S.
    Degenhardt, L.
    Krajden, M.
    Janjua, N.
    Grebely, J.
    Bruneau, J.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 131 - 131
  • [10] Young people with heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)
    Mills, KL
    Teesson, M
    Darke, S
    Ross, J
    Lynskey, M
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2004, 27 (01) : 67 - 73